| Robert M Yeh, MD | |
|
259 N Pecos Rd, Suite 110, Henderson, NV 89074-7365 | |
| (702) 309-0888 | |
| (702) 309-0868 |
| Full Name | Robert M Yeh |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 29 Years |
| Location | 259 N Pecos Rd, Henderson, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689856643 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 9877 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Rose Dominican Hospitals - Siena Campus | Henderson, NV | Hospital |
| Spring Valley Hospital Medical Center | Las vegas, NV | Hospital |
| Entity Name | Robert M Yeh Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073573309 PECOS PAC ID: 6800851452 Enrollment ID: O20041123000865 |
News Archive
Nutrisystem, Inc., a leading developer of weight loss products and services, today announced its company-wide support for the recently launched Stop DiabetesSM movement from the American Diabetes Association. On the heels of the successful launch of Nutrisystem D, its program designed to help people with type 2 diabetes lose weight, Nutrisystem has implemented a $5.00 contribution for every person who shares their story on the American Diabetes Association's Stop Diabetes website, up to $100,000 through December 31, 2009.
Now, a new study addresses the possible use of an FDA-approved monoclonal antibody, called fostamatinib, a spleen tyrosine kinase inhibitor (SYK), to reduce the levels of mucin-1, a molecule associated with acute lung injury and acute respiratory distress syndrome (ARDS). People who have severe COVID-19 disease may develop ARDS.
Tests for the coronavirus are supposed to be free. And, usually, they are. But sometimes … things happen. Here's how to keep those things from happening to you.
The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions in Washington, DC, Maryland, Alabama and New Jersey.
A new study identifies a molecule that is a probable driving force in colorectal cancer and suggests that the molecule could be an important target for colorectal cancer treatment and a valuable biomarker of tumor progression.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert M Yeh, MD Po Box 93838, Las Vegas, NV 89193-3838 Ph: (702) 309-0888 | Robert M Yeh, MD 259 N Pecos Rd, Suite 110, Henderson, NV 89074-7365 Ph: (702) 309-0888 |
News Archive
Nutrisystem, Inc., a leading developer of weight loss products and services, today announced its company-wide support for the recently launched Stop DiabetesSM movement from the American Diabetes Association. On the heels of the successful launch of Nutrisystem D, its program designed to help people with type 2 diabetes lose weight, Nutrisystem has implemented a $5.00 contribution for every person who shares their story on the American Diabetes Association's Stop Diabetes website, up to $100,000 through December 31, 2009.
Now, a new study addresses the possible use of an FDA-approved monoclonal antibody, called fostamatinib, a spleen tyrosine kinase inhibitor (SYK), to reduce the levels of mucin-1, a molecule associated with acute lung injury and acute respiratory distress syndrome (ARDS). People who have severe COVID-19 disease may develop ARDS.
Tests for the coronavirus are supposed to be free. And, usually, they are. But sometimes … things happen. Here's how to keep those things from happening to you.
The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions in Washington, DC, Maryland, Alabama and New Jersey.
A new study identifies a molecule that is a probable driving force in colorectal cancer and suggests that the molecule could be an important target for colorectal cancer treatment and a valuable biomarker of tumor progression.
› Verified 5 days ago
James B Gabroy, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1535 West Warm Spring Road, Suite 135, Henderson, NV 89014 Phone: 702-450-3385 Fax: 702-898-1699 | |
Dr. Poupak Ziaei, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2641 W Horizon Ridge Pkwy Ste 100, Henderson, NV 89052 Phone: 702-616-0091 Fax: 702-616-2329 | |
Dr. Jeannette Nee, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2865 Siena Heights Dr, Suite 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 | |
Wen Liang, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2621 W Horizon Ridge Pkwy, Suite 150, Henderson, NV 89052 Phone: 702-837-6368 Fax: 702-837-0685 | |
Randy James Ip, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2865 Siena Heights Dr Ste 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 | |
Linda Lou Johnson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1501 W Sunset Rd, Henderson, NV 89014 Phone: 725-269-7001 Fax: 725-269-7003 | |
Dr. Daejoon Anh, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2865 Siena Heights Dr Ste 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 |